New Concept of Onco-Hypertension and Future Perspectives.

Hypertension
Satoshi KidoguchiAkira Nishiyama

Abstract

Owing to aging populations, the prevalence of hypertension and associated cardiovascular events has been increasing worldwide. The morbidity and mortality due to cancer have also been increasing with aging populations. Several small-molecule inhibitors have been used in cancer therapy, which have a positive impact on the prognosis and survival of patients with cancer. Consequently, the number of cancer survivors with hypertension has been rapidly increasing. Anticancer therapy, including vascular endothelial growth factor inhibitors, increases blood pressure. However, both clinical and laboratory evidence are lacking regarding optimal blood pressure control in patients with hypertension with cancer. Here, we propose the concept of onco-hypertension, which is an evolving subspecialty focused on the complex pathophysiology of hypertension and cancer. In this review, we highlight blood pressure changes in cancer, hypertension induced by anticancer therapy, and optimal blood pressure management in patients with hypertension with cancer. In addition, we discuss needed studies to further establish this new onco-hypertension concept.

References

Sep 1, 1996·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Y ImaiK Abe
Apr 8, 1998·The American Journal of Physiology·J D HoodH J Granger
Aug 19, 1999·Journal of Gastroenterology·H AraiM Mori
Aug 24, 1999·Hypertension·M SolerC la Vecchia
Oct 22, 2003·Journal of the American Society of Nephrology : JASN·William G Kaelin
Apr 8, 2004·Journal of the National Cancer Institute·Jing MaMeir J Stampfer
May 27, 2004·JAMA : the Journal of the American Medical Association·Jay F PiccirilloEdward L Spitznagel
Oct 13, 2004·Neuroendocrinology·Anouk N A van der Horst-SchriversElisabeth G E de Vries
Aug 4, 2006·Journal of Human Hypertension·J A LargentH Anton-Culver
Jan 31, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Xiaolei ZhuChirag R Parikh
Dec 7, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Antonio RussoLuigi Bisanti
Dec 7, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-J MouradB I Levy
Jan 4, 2008·The New England Journal of Medicine·Michel AziziStéphane Oudard
Mar 14, 2008·The New England Journal of Medicine·Vera EreminaSusan E Quaggin
Feb 27, 2010·American Journal of Hypertension·Vishal RanpuraShenhong Wu
Mar 31, 2010·Journal of the National Cancer Institute·Michael L MaitlandUNKNOWN Cardiovascular Toxicities Panel, Convened by the Angiogenesis Task Force of the National Cancer Institute Investigational Dr
Apr 17, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Claudio PelucchiCarlo La Vecchia
Sep 30, 2010·Investigational New Drugs·Olivier MirFrançois Goldwasser
Oct 7, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J CortesJ Baselga
Dec 23, 2011·Journal of Hypertension·Hisatomi ArimaJohn Chalmers
Feb 3, 2012·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Lanfranco D'EliaPasquale Strazzullo
Aug 2, 2012·Hypertension·Nilka de Jesus-GonzalezBenjamin D Humphreys
Oct 24, 2012·Cancer·Christel HäggströmPär Stattin
May 15, 2013·The Journal of Urology·Liam C MacleodEmily White
Jun 21, 2013·International Journal of Cancer. Journal International Du Cancer·Alberto MilanFranco Veglio
Jun 1, 2011·Cancer·Tanja StocksUNKNOWN Metabolic Syndrome Cancer Project Me-Can Group
Mar 1, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rana R McKayToni K Choueiri
Jun 27, 2015·Journal of the American College of Cardiology·Ana BaracPamela S Douglas
Sep 16, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Javid J Moslehi, Michael Deininger
Jan 17, 2016·Japanese Journal of Clinical Oncology·Kiyohiko HatakeKuniaki Shirao
Mar 16, 2016·Circulation·Ryan J KoeneSuma H Konety
Oct 13, 2016·JAMA Cardiology·Husam Abdel-QadirGeoffrey M Anderson

❮ Previous
Next ❯

Citations

Mar 20, 2021·Cardiovascular Research·Andrea CignarellaMatthias Barton
Jun 8, 2021·Frontiers in Oncology·José A Carlos-EscalanteTalia Wegman-Ostrosky

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.